Abstract
This Practice Point commentary discusses the study by Gosselaar et al. that reports the performance characteristics of digital rectal examination (DRE) in men from the Rotterdam cohort of the European Randomized Study of Screening for Prostate Cancer. The authors reported that the positive predictive value of DRE for detecting the presence of prostate cancer was 48.6% in the first round of screening, decreasing to 29.9% and 21.2% in the second and third rounds, respectively. Nevertheless, an abnormal DRE was associated with a significantly increased risk of very high-grade disease during all screening rounds, indicating that it provides useful additional prognostic information. This study adds to a considerable body of evidence supporting a role for DRE in early detection of prostate cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gosselaar C et al. (2008) The role of the digital rectal examination in subsequent screening visits in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam. Eur Urol 54: 581–588
Okotie OT et al. (2007) Characteristics of prostate cancer detected by digital rectal examination only. Urology 70: 1117–1120
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
WJ Catalona has received grant/research support and speakers' honoraria, and been a consultant for, Beckman Coulter Inc. and deCODE genetics Inc.
Rights and permissions
About this article
Cite this article
Loeb, S., Catalona, W. What is the role of digital rectal examination in men undergoing serial screening of serum PSA levels?. Nat Rev Urol 6, 68–69 (2009). https://doi.org/10.1038/ncpuro1294
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro1294
This article is cited by
-
Guidance on Patient Consultation. Current Evidence for Prostate-Specific Antigen Screening in Healthy Men and Treatment Options for Men with Proven Localised Prostate Cancer
Current Urology Reports (2015)
-
Biopsie der Prostata
Der Urologe (2014)
-
Role of 18F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer
European Journal of Nuclear Medicine and Molecular Imaging (2013)
-
The implementation of screening for prostate cancer
Prostate Cancer and Prostatic Diseases (2010)